Metronidazole Dosing in Pediatric Patients
For most pediatric infections requiring metronidazole, use 30-40 mg/kg/day divided every 8 hours (maximum 500 mg per dose), with dosing adjustments based on the specific clinical scenario. 1
Standard Dosing by Clinical Indication
General Anaerobic Infections
- Administer 30-40 mg/kg/day divided every 8 hours, with a maximum of 500 mg per dose 1
- The FDA-approved pediatric dosing for amebiasis is 35-50 mg/kg/24 hours divided into three doses for 10 days 2
- For serious anaerobic infections, the adult-equivalent oral dosing is 7.5 mg/kg every 6 hours (approximately 500 mg for a 70 kg adult) 2
- Standard treatment duration is 7-10 days for most infections, though bone/joint, lower respiratory tract, and endocardial infections may require longer courses 2
Intra-Abdominal Infections
- Use 30-40 mg/kg/day divided every 8 hours as part of combination therapy 1
- Combine with aminoglycosides, carbapenems, or advanced-generation cephalosporins for complicated infections 1
- For mixed necrotizing infections requiring anaerobic coverage, use 7.5 mg/kg/dose every 6 hours IV, typically combined with cefotaxime (50 mg/kg/dose every 6 hours) 1
Clostridioides difficile Infection (CDI)
Non-Severe CDI:
- Administer 7.5 mg/kg/dose three or four times daily (maximum 500 mg per dose) for 10 days 3, 4
- This dosing is LOWER than for other anaerobic infections (10-13 mg/kg/dose) 1
- Oral vancomycin (10 mg/kg/dose four times daily, maximum 125 mg per dose) is an alternative 4
Severe or Fulminant CDI:
- Oral vancomycin is strongly recommended over metronidazole (strong recommendation, moderate quality evidence) 3
- If metronidazole must be used in severe infections, administer 10 mg/kg/dose three times daily IV (maximum 500 mg per dose) 3
Recurrent CDI:
- For first recurrence after metronidazole: use oral vancomycin 10 mg/kg/dose four times daily (maximum 125 mg per dose) for 10 days 4
- For second or subsequent recurrences: oral vancomycin is recommended over metronidazole (weak recommendation, low quality evidence) 3
- Avoid repeated or prolonged metronidazole courses due to peripheral neuropathy risk 4
Perianal Fistulizing Crohn's Disease
- Use 10-20 mg/kg/day in divided doses 5, 1
- Ciprofloxacin 20 mg/kg/day is an alternative or adjunctive option 5
- These antibiotics offer good short-term response and may bridge to immunosuppressive medications 5
Age-Specific Dosing Considerations
Neonates
- Dosing varies significantly by postnatal age and weight 5
- Postnatal age ≤7 days and ≤2000 g: 7.5 mg/kg every 12 hours 5
- Postnatal age ≤7 days and >2000 g: 7.5-10 mg/kg every 12 hours 5
- Postnatal age >7 days and <1200 g: 7.5-10 mg/kg every 8-12 hours 5
- Postnatal age >7 days and >2000 g: 10 mg/kg every 8 hours 5
Infants and Children
- Standard dosing: 15-22.5 mg/kg/day divided every 8 hours 5
- Some patients may require up to 30 mg/kg/day divided every 8 hours based on serum levels (e.g., cystic fibrosis or febrile neutropenic patients) 5
Alternative Dosing Strategies
Once-Daily Dosing for Appendicitis
- Recent pharmacokinetic data supports 30 mg/kg per dose once daily for pediatric appendicitis 6
- This achieves AUC/MIC ratio ≥70 for Bacteroides fragilis with MIC ≤2 mcg/mL in 96-100% of patients 6
- Target attainment decreases for higher MICs (61-97% for MIC 4 mcg/mL; 9-71% for MIC 8 mcg/mL) 6
- This dosing strategy is based on metronidazole's long half-life, concentration-dependent killing, and 3-hour postantibiotic effect 6
Special Populations and Considerations
Malnourished Children
- Severe malnutrition requires a 60% dose reduction to 12 mg/kg/day to avoid drug accumulation 7
- Biotransformation is significantly impaired in malnourished children, leading to elevated plasma concentrations 7
- This dosing maintains therapeutic plasma concentrations of 6.0 mcg/mL 7
Hepatic Impairment
- Patients with severe hepatic disease metabolize metronidazole slowly, requiring cautious dose reduction 2
- Close monitoring of plasma metronidazole levels and toxicity is recommended 2
Renal Impairment
- Do not specifically reduce doses in anuric patients since accumulated metabolites are rapidly removed by dialysis 2
Route of Administration
- Intravenous metronidazole is usually administered initially for most serious anaerobic infections 2
- Transition to oral therapy is appropriate once clinical improvement occurs 8
- In one study, patients received initial parenteral therapy for 5-21 days (average 11.6 days) before transitioning to oral therapy 8
Common Pitfalls and Caveats
- Do not use the same dosing for CDI as for other anaerobic infections—CDI requires lower doses (7.5 mg/kg/dose vs. 10-13 mg/kg/dose) 1
- Avoid metronidazole in first-trimester pregnancy (contraindicated) 2
- Do not exceed 4 g in 24 hours regardless of indication 2
- Monitor for peripheral neuropathy with prolonged or repeated courses 4
- Therapeutic drug monitoring may be necessary in elderly patients, those with hepatic impairment, or malnourished children 2, 7
- Peak concentrations on day 3 of therapy typically range from 15.2-30 mcg/mL, with trough levels of 4-11.6 mcg/mL 8